Patients who received botox injections at four different sites, not just the forehead, reported anxiety significantly less than those undergoing different treatments for the same conditions.
Dopamine neurons largely rely on their own discharge to determine release rates of the hormone, researchers report.
Genetically engineering botulinum toxin could help advance new treatments for everything from neurodegenerative disorders to cytokine storms.
Botox injections appear to improve symptoms of depression, regardless of the injection site, a new study reports. Researchers found depression was reported 40 - 88% less often in patients treated with Botox.
Many people who suffer migraines are often diagnosed with other conditions. For those with a clinical diagnosis, many are unaware of treatment options available for pain and to slow the frequency of attacks.
According to researchers, Botulinum toxin, or Botox, injections can help to reduce the frequency of chronic migraines. Compared to those treated with a placebo, migraine suffers experienced 1.6 fewer attacks per month following Botox injections.
Researchers have identified a new active botulinum neurotoxin. The discovery could lead to the development of new protein therapeutics.
A new study backs up previous research regarding the effectiveness of ketamine in treating depression. Additionally, researchers identified antidepressant effects in Botox, Diclofenac and Minocycline, drugs commonly used for other purposes.
A new method of growing neural networks from stem cells is capable of detecting the activity of Clostridium botulinum neurotoxins and could help to minimize animal research.
Researchers report botox may spread from the injection site to produce symptoms consistent with botulism, including muscle weakness and breathing problems.
Researchers pinpoint a method to neutralize the Botox toxin.
A new study reports Botox treatments temporarily block proprioceptive feedback, essentially making it difficult for others to read emotion from facial expressions.
